Apogee Therapeutics, Inc. 10-Q filing
Filed 2026-05-11 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-215698
- Form type
- 10-Q
- CIK
- 0001974640
- Primary document
- https://www.sec.gov/Archives/edgar/data/1974640/000119312526215698/apge-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Apogee Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-82.8M | - | - |
| Net Income | $-74.1M | - | - |
| Eps Basic | -1.06 | - | - |
| Eps Diluted | -1.06 | - | - |
| Cash And Equivalents | $451.8M | - | - |
| Total Assets | $1.3B | - | - |
| Total Liabilities | $37.9M | - | - |
| Operating Cash Flow | $-55.6M | - | - |
| Capital Expenditures | $4.3M | - | - |